Characteristics of T-cell and B-cell receptor repertoires in patients with autoimmune hepatitis
Eurasian Journal of Medicine and Oncology · 2025-10-27 · 10 (5) · 025230234
DOI: 10.36922/ejmo025230234 ↗Abstract
Introduction: Autoimmune hepatitis (AIH) is a chronic liver disease characterized by inflammation resulting from the body’s immune system attacking its own liver cells. T-cell receptor (TCR) and B-cell receptor (BCR) repertoires are crucial mediators of autoimmune diseases, with the cause of B-lineage dysregulation remaining elusive. Objective: This study aims to comprehensively describe the changes in TCR and BCR repertoires in the peripheral blood and liver of patients with AIH. Methods: High-throughput sequencing and multiplex polymerase chain reaction amplification were applied to explore the TCR and BCR gene repertoire characteristics in 60 patients with AIH and control groups. Results: The findings revealed a significant reduction in the diversity of BCR heavy-chain (BCR-H) repertoire and the length of BCR-H complementarity-determining region 3 (CDR3) in the peripheral blood of AIH patients. Interestingly, the pre-selection BCR-H CDR3s in AIH patients were abnormally short, suggesting irregularities in the early stages of B-cell development and repertoire formation in the bone marrow. Furthermore, compared with controls, peripheral blood samples from AIH patients showed reduced diversity in the TCR β-chain (TCR-β) repertoire, longer CDR3 lengths, biased TCR-β variable gene usage, and extensive TCR-β sharing. The analysis revealed a comparable distribution of clone diversity between liver tissue samples from AIH and control groups, potentially attributable to the architectural characteristics of AIH liver T and B cells, which are marked by the presence of multiple antigen-responsive T and B cells rather than a single reactive T and B lymphocyte clone. Conclusion: This study reveals distinct alterations in the TCR and BCR repertoires among patients with AIH, potentially offering novel insights for its prevention and diagnosis.
EUVIMED